BMCM
ZBH icon

Bryn Mawr Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bryn Mawr Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$765K Sell
8,883
-1,242
-12% -$109K 0.03% 238
2026
Q1 		$915K Sell
10,125
-29,699
-75% -$2.73M 0.04% 219
2025
Q4 		$3.58M Sell
39,824
-25,448
-39% -$2.41M 0.17% 115
2025
Q3 		$6.43M Buy
65,272
+2,030
+3% +$201K 0.32% 79
2025
Q2 		$5.77M Buy
63,242
+5,229
+9% +$506K 0.32% 80
2025
Q1 		$6.57M Buy
58,013
+8,730
+18% +$934K 0.39% 68
2024
Q4 		$5.21M Sell
49,283
-2,929
-6% -$314K 0.28% 81
2024
Q3 		$5.64M Sell
52,212
-25,619
-33% -$2.8M 0.3% 78
2024
Q2 		$8.45M Buy
77,831
+3,543
+5% +$418K 0.47% 55
2024
Q1 		$9.8M Buy
74,288
+4,918
+7% +$614K 0.56% 48
2023
Q4 		$8.44M Sell
69,370
-245
-0.4% -$27.3K 0.53% 47
2023
Q3 		$7.81M Buy
69,615
+7,603
+12% +$966K 0.51% 47
2023
Q2 		$9.03M Buy
62,012
+819
+1% +$111K 0.85% 30
2023
Q1 		$7.91M Sell
61,193
-1,990
-3% -$250K 0.82% 32
2022
Q4 		$8.06M Buy
+63,183
New +$7.33M 0.87% 32

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bryn Mawr Capital Management's ZBH Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, selling an estimated $109K and leaving 8,883 shares worth $765K. The position accounts for 0.03% of the portfolio, ranked #238.

Bryn Mawr Capital Management first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.8M in Q1 2024. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Bryn Mawr Capital Management held 8,883 shares of Zimmer Biomet worth $765K as of Q2 2026.
  • Bryn Mawr Capital Management sold 1,242 Zimmer Biomet shares in Q2 2026, an estimated $109K.
  • Zimmer Biomet made up 0.03% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #238 holding.
  • Bryn Mawr Capital Management first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Bryn Mawr Capital Management's Zimmer Biomet position peaked at $9.8M in Q1 2024.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.